A trio of insider traders banked about $530,000 on tips from within Ardea Biosciences, according to the SEC, buying shares ahead of major news right up until AstraZeneca ($AZN) bought the company for $1.3 billion.
http://www.fiercebiotech.com/story/sec-insider-traders-lined-their-pockets-astrazenecas-13b-ardea-deal/2015-06-09?utm_medium=rss&utm_source=feedly&utm_campaign=rss
http://www.fiercebiotech.com/story/sec-insider-traders-lined-their-pockets-astrazenecas-13b-ardea-deal/2015-06-09?utm_medium=rss&utm_source=feedly&utm_campaign=rss
No comments:
Post a Comment